ArticlePathology oncology research : POR2025

Evaluating an RNA-based test for proliferation assessment and recurrence prediction in early HR+/HER2- breast cancer.

Marcus Vetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.